Manchester, NH, United States of America

Vladimir Presnyak

This inventor holds 42 USPTO granted patents and 42 published patent applications and 11 EPO patents, primarily in Gene Editing Technologies. Top assignees: Modernatx, Inc., Renagade Therapeutics Management Inc., Fundacion Para La Investigacion Medica Aplicada. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Presnyak. Retrieved from https://idiyas.com/inventor/vladimir-presnyak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 42 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 170(Granted Patents)


Location History:

  • Hooksett, NH (US) (2020)
  • Cambridge, MA (US) (2019 - 2024)
  • Manchester, NH (US) (2019 - 2024)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Polynucleotides
Gene Editing
mRNA Therapy
Cystic Fibrosis
Acute Intermittent Porphyria
Cancer Treatment
Hyperlipidemia
Galactosemia
Zoonotic Disease
Immune Modulating Polypeptides
Functional RNA Elements
Urea Cycle Disorders
42 patents (USPTO):Explore Patents

Title: Vladimir Presnyak: A Pioneer in Technology and Innovation

Introduction:

Vladimir Presnyak, a visionary inventor based in Manchester, NH (US), is renowned for his relentless pursuit of innovation in the realm of technology. With 30 patents to his name, Presnyak has solidified his reputation as a pioneering force in creating solutions to complex challenges.

Latest Patents:

Among his latest patents is the groundbreaking work titled "Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders." This innovative disclosure focuses on mRNA therapy for treating ornithine transcarbamylase deficiency, showcasing Presnyak's commitment to developing life-changing medical solutions. Additionally, his patent on high fidelity in vitro transcription highlights his expertise in ensuring accuracy and precision in molecular processes.

Career Highlights:

Currently affiliated with Moderna Inc., Presnyak has made significant contributions to the field of biotechnology through his inventive projects. His role in developing cutting-edge therapies underscores his dedication to advancing healthcare and improving patient outcomes.

Collaborations:

Throughout his career, Presnyak has collaborated with esteemed colleagues such as Kerry Benenato and Iain McFadyen. These partnerships have fostered a culture of innovation and intellectual exchange, further enhancing Presnyak's ability to push the boundaries of technological advancement.

Conclusion:

In conclusion, Vladimir Presnyak's unwavering passion for innovation and his substantial contributions to the technology sector have established him as a pioneering inventor. His inventive spirit, coupled with a commitment to addressing critical challenges, continues to shape the landscape of technological innovation in remarkable ways.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…